TP53 and lung adenocarcinoma: In A549 lung adenocarcinoma cells, CRISPR-Cas9-mediated knockout of wild-type p53 resulted in the transcriptional activation of MMD, upregulating the expression of PAQR11 (Progestin and adipoQ receptor 11) [81].